Search Within

Irina Ostrovnaya

Formats
  1. Journal Article (118)
  2. Meeting Abstract (81)
  3. Review (1)
Groups
  1. Biostatistics Service (200)
  2. Epidemiology and Biostatistics (200)
  3. Department of Medicine (140)
  4. Solid Tumor Oncology Division (139)
  5. Genitourinary Oncology Service (127)
  6. Surgery (112)

More Groups

People
  1. Dean Bajorin (87)
  2. Gopakumar Iyer (71)
  3. Jonathan Rosenberg (68)
  4. Hikmat Al-Ahmadie (60)
  5. David Solit (54)
  6. Ashley Regazzi (47)

More People

Years
  1. 2025 (8)
  2. 2024 (15)
  3. 2023 (7)
  4. 2022 (15)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (74)
  2. Clinical Cancer Research (10)
  3. Urologic Oncology: Seminars and Original Investigations (8)
  4. Cancer Research (7)
  5. European Urology (6)
  6. Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. American Association for Cancer Research (22)
  3. Wiley Blackwell (14)
  4. Elsevier Inc. (13)
  5. Elsevier Science, Inc. (11)
  6. Nature Publishing Group (10)

More Publishers

Results (200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial
    Meeting Abstract

    Gonzalez, C. M.; Jordan, E.; Zabor, E. C.; Kania, B. E.; Regazzi, A. M.; Ostrovnaya, I.; Iyer, G.; Bajorin, D. F.; Bambury, R. M.; Rosenberg, J. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer
    Meeting Abstract

    Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; Bajorin, D. F.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Osteochondroma in long-term survivors of high-risk neuroblastoma
    Journal Article

    Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
    Cancer (2015)

    Fulltext@MSK | Save
  • The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: A large single-institution experience
    Journal Article

    Bambury, R. M.; Benjamin, D. J.; Chaim, J. L.; Zabor, E. C.; Sullivan, J.; Garcia-Grossman, I. R.; Regazzi, A. M.; Ostrovnaya, I.; Apollo, A.; Xiao, H.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy
    Journal Article

    Cheung, N. K. V.; Ostrovnaya, I.; Kuk, D.; Cheung, I. Y.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
    Journal Article

    Sankin, A.; Hakimi, A. A.; Mikkilineni, N.; Ostrovnaya, I.; Silk, M. T.; Liang, Y.; Mano, R.; Chevinsky, M.; Motzer, R. J.; Solomon, S. B.; more...
    Cancer Medicine (2014)

    Fulltext@MSK | Save
  • Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive urothelial carcinoma
    Meeting Abstract

    Rosenberg, J. E.; Van Allen, E. M.; Mouw, K. W.; Kim, P. H.; Wagle, N.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
    Journal Article

    Kim, P. H.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Zabor, E. C.; Scott, S. N.; Ostrovnaya, I.; Ramirez, R.; Sun, A.; Shah, R.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?
    Journal Article

    Cheung, N. K. V.; Modak, S.; Ostrovnaya, I.; Roberts, S. S.; Basu, E. M.; Kramer, K.; Kushner, B. H.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Somatic ERCC2 mutations confer cisplatin sensitivity in muscle-invasive urothelial cancer
    Meeting Abstract

    Mouw, K.; Van Allen, E.; O'connor, K.; Wagle, N.; Kim, P.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save